| Deler fremragende | 26,832,457 shares |
| Insideraktier | 1.118.641 shares |
| Insider ejerskab | 4,17 % |
| Total Insiders | 61 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Syros Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Noubar Afeyan
10% Owner -
|
0 | 0 | |
|
Aisling Capital Iii Lp
10% Owner -
|
908.565 | 90.856 | |
| Srinivas Akkaraju Director - [D] | 9.333 | 9.333 | |
|
ARCH Venture Partners VII, L.P.
10% Owner -
|
4.242.051 | 424.205 | |
|
ARCH Venture Partners VII, LLC
10% Owner -
|
4.242.051 | 424.205 | |
|
Aisling Capital Partners III LLC
10% Owner -
|
908.565 | 90.856 | |
|
Aisling Capital Partners III LP
10% Owner -
|
908.565 | 90.856 | |
| Mark J Alles Director - [D] | 3.666 | 3.666 | |
|
Arch Venture Fund VII LP
10% Owner -
|
4.242.051 | 424.205 | |
| Michael W Bonney | 11.000 | ||
|
Clinton Bybee
10% Owner -
|
4.242.051 | 424.205 | |
| Stephane Bancel Director - [D] | 47.980 | 4.798 | |
|
Keith Crandell
10% Owner -
|
4.242.051 | 424.205 | |
| Conley Chee President & CEO, Director - [D] [O] | 0 | 0 | |
|
Management Co Deerfield
10% Owner -
|
628.566 | 62.857 | |
| Colleen Elizabeth DeSimone Principal Accounting Officer - [O] | 0 | 0 | |
|
Deerfield Mgmt III, L.P.
10% Owner -
|
628.566 | 62.857 | |
|
Deerfield Mgmt L.P.
10% Owner -
|
628.566 | 62.857 | |
|
Deerfield Private Design Fund III, L.P.
10% Owner -
|
628.566 | 62.857 | |
|
Deerfield Special Situations Fund, L.P.
10% Owner -
|
628.566 | 62.857 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Deborah Dunsire Director - [D] | 12.000 | 12.000 | |
|
Steve Elms
10% Owner -
|
908.565 | 90.856 | |
| Sue Gail Eckhardt Director - [D] | 16.000 | 16.000 | |
| Marsha Fanucci Director - [D] | 16.000 | 16.000 | |
| Joseph J Jr Ferra Chief Financial Officer - [O] | 87.000 | 8.700 | |
|
Flagship VentureLabs IV, LLC
10% Owner -
|
0 | 0 | |
|
Flagship Ventures Fund IV General Partner LLC
10% Owner -
|
0 | 0 | |
|
Flagship Ventures Fund IV, L.P.
10% Owner -
|
0 | 0 | |
|
Flagship Ventures Fund IV-Rx, L.P.
10% Owner -
|
0 | 0 | |
|
James E Flynn
10% Owner -
|
628.566 | 62.857 | |
|
Nathanael Gray
10% Owner -
|
853.332 | 85.333 | |
|
Jeremy Green
10% Owner -
|
49.793 | 4.979 | |
| Jason Haas Chief Financial Officer - [O] | 0 | 0 | |
|
JEB Syros Trust
10% Owner -
|
703.332 | 70.333 | |
|
Edwin M Jr Kania
10% Owner -
|
0 | 0 | |
| Kuvalanka Kyle D. | 78.000 | ||
|
Robert Nelsen
10% Owner -
|
4.242.051 | 424.205 | |
|
Amir Nashat
Director, 10% Owner -
[D]
|
48.320 | 4.832 | |
| Oh Andrew M. Director - [D] | 16.000 | 16.000 | |
| Eric R Olson Chief Scientific Officer - [O] | 6.661 | 6.661 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Sanj K Patel | 11.000 | ||
|
Perspecta Trust LLC
10% Owner -
|
703.332 | 70.333 | |
|
Polaris Entrepreneurs' Fund VII, L.P.
10% Owner -
|
48.320 | 4.832 | |
|
Polaris Management Co. VII, L.L.C.
10% Owner -
|
48.320 | 4.832 | |
|
Polaris Partners VII, L.P.
10% Owner -
|
48.320 | 4.832 | |
|
Dennis J Purcell
10% Owner -
|
908.565 | 90.856 | |
| Gerald E Quirk Chief Legal & Compliance Offic - [O] | 0 | 0 | |
|
Redmile Group, LLC
10% Owner -
|
49.793 | 4.979 | |
| David Roth Chief Medical Officer - [O] | 0 | 0 | |
| Vicki L Sato | 11.000 | ||
|
Andrew N Schiff
10% Owner -
|
908.565 | 90.856 | |
| Philip A Sharp Director - [D] | 40.000 | 4.000 | |
| Alice Tsang Shaw | 22.000 | ||
| Nancy A Simonian Director - [D] | 4.000 | 4.000 | |
| Springhorn Jeremy P. Chief Business Officer - [O] | 35.000 | 3.500 | |
| Kristin Stephens Chief Development Officer - [O] | 0 | 0 | |
| Timothy Tyson Director - [D] | 33.189 | 33.189 | |
| Peter Wirth Director - [D] | 16.000 | 16.000 | |
|
WuXi Healthcare Ventures II, L.P.
10% Owner -
|
423.805 | 42.380 | |
|
WuXi PharmTech Healthcare Fund I L.P.
10% Owner -
|
931.857 | 93.186 | |
| Richard A Young Director - [D] | 10.667 | 10.667 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SYRS / Syros Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SYRS / Syros Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-04 | 2024-12-02 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 0,2702 | -37.070 | -10 | 4.000 | ||||
| 2024-11-27 | 2024-11-25 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 0,2653 | -134.713 | -36 | 41.070 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Haas Jason | SYRS | Common Stock | D | 0,2103 | -137.803 | -29 | 0 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Chee Conley | SYRS | Common Stock | D | 0,1998 | -134.797 | -27 | 0 | ||||
| 2024-11-20 | 2024-11-19 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 0,2212 | -46.657 | -10 | 0 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Stephens Kristin | SYRS | Common Stock | D | 0,2200 | -36.133 | -8 | 0 | ||||
| 2024-11-20 | 2024-11-18 | 4 | Roth David | SYRS | Common Stock | D | 0,1969 | -12.099 | -2 | 0 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 40.125 | 175.783 | ||||||
| 2024-11-04 | 2024-10-31 | 4 | Chee Conley | SYRS | Common Stock | D | 2,0900 | -8.707 | -18 | 130.797 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Chee Conley | SYRS | Common Stock | D | 17.000 | 139.504 | ||||||
| 2024-11-04 | 2024-10-31 | 4 | Roth David | SYRS | Common Stock | D | 2,0900 | -6.776 | -14 | 12.099 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Roth David | SYRS | Common Stock | D | 18.875 | 18.875 | ||||||
| 2024-11-04 | 2024-10-31 | 4 | Haas Jason | SYRS | Common Stock | D | 2,0900 | -5.624 | -12 | 137.803 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Haas Jason | SYRS | Common Stock | D | 18.875 | 143.427 | ||||||
| 2024-11-04 | 2024-10-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2,0900 | -6.104 | -13 | 36.133 | ||||
| 2024-11-04 | 2024-10-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 17.000 | 42.237 | ||||||
| 2024-10-02 | 2024-09-30 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 2,1000 | -3.100 | -7 | 46.657 | ||||
| 2024-10-02 | 2024-09-30 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 10.000 | 49.757 | ||||||
| 2024-09-18 | 2024-09-16 | 4 | Young Richard A | SYRS | Common Stock | D | 2.667 | 10.667 | ||||||
| 2024-09-18 | 2024-09-16 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | D | 2.667 | 9.333 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Chee Conley | SYRS | Common Stock | D | 1,7084 | 50.000 | 85 | 122.504 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Chee Conley | SYRS | Common Stock | D | 1,5052 | 50.000 | 75 | 72.504 | ||||
| 2024-09-12 | 2024-09-12 | 4 | Haas Jason | SYRS | Common Stock | D | 1,6762 | 45.344 | 76 | 124.552 | ||||
| 2024-09-12 | 2024-09-11 | 4 | Haas Jason | SYRS | Common Stock | D | 1,5781 | 19.293 | 30 | 79.208 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Haas Jason | SYRS | Common Stock | D | 1,5493 | 35.363 | 55 | 59.915 | ||||
| 2024-07-02 | 2024-06-28 | 4 | Young Richard A | SYRS | Common Stock | D | 5,1200 | -34.837 | -178 | 8.000 | ||||
| 2024-06-07 | 2024-06-05 | 4 | OH ANDREW M. | SYRS | Common Stock | D | 4.000 | 16.000 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 4.000 | 135.658 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | WIRTH PETER | SYRS | Common Stock | D | 4.000 | 16.000 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Fanucci Marsha | SYRS | Common Stock | D | 4.000 | 16.000 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Eckhardt Sue Gail | SYRS | Common Stock | D | 4.000 | 16.000 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 4.000 | 33.189 | ||||||
| 2024-06-07 | 2024-06-05 | 4 | Young Richard A | SYRS | Common Stock | D | 4.000 | 42.837 | ||||||
| 2024-06-04 | 2024-06-01 | 4 | Dunsire Deborah | SYRS | Common Stock | D | 4.000 | 12.000 | ||||||
| 2024-06-04 | 2024-06-01 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | D | 4.000 | 6.666 | ||||||
| 2024-04-05 | 2024-04-03 | 4 | Roth David | SYRS | Common Stock | D | 4,9500 | -10.451 | -52 | 0 | ||||
| 2024-04-02 | 2024-04-01 | 4 | Stephens Kristin | SYRS | Common Stock | D | 5,1200 | -4.218 | -22 | 25.237 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 11.666 | 29.455 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2.000 | 17.789 | ||||||
| 2024-04-02 | 2024-04-01 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 5,1200 | -14.052 | -72 | 131.658 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 39.566 | 145.710 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 6.000 | 106.144 | ||||||
| 2024-04-02 | 2024-04-02 | 4 | Roth David | SYRS | Common Stock | D | 4,9803 | -150 | -1 | 10.451 | ||||
| 2024-04-02 | 2024-04-01 | 4 | Roth David | SYRS | Common Stock | D | 5,1200 | -4.732 | -24 | 10.601 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Roth David | SYRS | Common Stock | D | 13.333 | 15.333 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Roth David | SYRS | Common Stock | D | 2.000 | 2.000 | ||||||
| 2024-04-02 | 2024-03-28 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 5,5900 | -7.046 | -39 | 39.757 | ||||
| 2024-04-02 | 2024-03-27 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 22.500 | 46.803 | ||||||
| 2024-04-02 | 2024-04-01 | 4 | Haas Jason | SYRS | Common Stock | D | 5,1200 | -4.732 | -24 | 24.552 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Haas Jason | SYRS | Common Stock | D | 13.333 | 29.284 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Haas Jason | SYRS | Common Stock | D | 2.000 | 15.951 | ||||||
| 2024-04-02 | 2024-04-01 | 4 | Chee Conley | SYRS | Common Stock | D | 5,1200 | -3.500 | -18 | 22.504 | ||||
| 2024-04-02 | 2024-03-31 | 4 | Chee Conley | SYRS | Common Stock | D | 11.666 | 26.004 | ||||||
| 2024-04-02 | 2024-03-31 | 4 | Chee Conley | SYRS | Common Stock | D | 2.000 | 14.338 | ||||||
| 2023-12-26 | 2023-12-21 | 4 | AKKARAJU SRINIVAS By Samsara BioCapital, L.P. | SYRS | Common Stock | I | 4,4200 | 904.977 | 4.000 | 1.786.427 | ||||
| 2023-12-14 | 2023-12-12 | 4 | Roth David | SYRS | Common Stock | D | 4,9500 | -6.287 | -31 | 0 | ||||
| 2023-12-08 | 2023-12-06 | 4 | Roth David | SYRS | Common Stock | D | 3,9500 | -6.287 | -25 | 6.287 | ||||
| 2023-11-02 | 2023-11-01 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 2,2200 | -13.401 | -30 | 100.144 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 40.125 | 113.545 | ||||||
| 2023-11-02 | 2023-11-01 | 4 | Haas Jason | SYRS | Common Stock | D | 2,2200 | -6.301 | -14 | 13.951 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Haas Jason | SYRS | Common Stock | D | 18.875 | 20.252 | ||||||
| 2023-11-02 | 2023-11-01 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2,2200 | -5.676 | -13 | 15.789 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 17.000 | 21.465 | ||||||
| 2023-11-02 | 2023-11-01 | 4 | Roth David | SYRS | Common Stock | D | 2,2200 | -6.301 | -14 | 12.574 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Roth David | SYRS | Common Stock | D | 18.875 | 18.875 | ||||||
| 2023-11-02 | 2023-11-01 | 4 | Chee Conley | SYRS | Common Stock | D | 2,2200 | -6.004 | -13 | 12.338 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Chee Conley | SYRS | Common Stock | D | 17.000 | 18.342 | ||||||
| 2023-10-20 | 2023-10-19 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 2,1000 | -6.897 | -14 | 24.303 | ||||
| 2023-10-20 | 2023-10-11 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 22.500 | 31.200 | ||||||
| 2023-09-19 | 2023-09-16 | 4 | Young Richard A | SYRS | Common Stock | D | 2.666 | 38.837 | ||||||
| 2023-09-19 | 2023-09-16 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | D | 2.666 | 2.666 | ||||||
| 2023-09-19 | 2023-09-16 | 4 | Alles Mark J | SYRS | Common Stock | D | 2.666 | 3.666 | ||||||
| 2023-08-02 | 2023-07-31 | 4 | Roth David | SYRS | Common Stock | D | 3,9500 | -7.348 | -29 | 0 | ||||
| 2023-07-18 | 2023-07-17 | 4 | Olson Eric R | SYRS | Common Stock | D | 3,5000 | -689 | -2 | 6.661 | ||||
| 2023-06-02 | 2023-06-01 | 4 | WIRTH PETER | SYRS | Common Stock | D | 4.000 | 12.000 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Young Richard A | SYRS | Common Stock | D | 4.000 | 36.171 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | OH ANDREW M. | SYRS | Common Stock | D | 4.000 | 12.000 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 4.000 | 29.189 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Eckhardt Sue Gail | SYRS | Common Stock | D | 4.000 | 12.000 | ||||||
| 2023-06-02 | 2023-06-01 | 4 | Fanucci Marsha | SYRS | Common Stock | D | 4.000 | 12.000 | ||||||
| 2023-04-20 | 2022-09-16 | 4/A | TYSON TIMOTHY | SYRS | Common Stock | D | 257 | 8.257 | ||||||
| 2023-04-20 | 2022-09-16 | 4/A | TYSON TIMOTHY | SYRS | Common Stock | D | 8.000 | 8.000 | ||||||
| 2023-04-20 | 2022-09-16 | 4/A | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 691.489 | 881.450 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Chee Conley | SYRS | Common Stock | D | 2,5800 | -658 | -2 | 1.342 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Chee Conley | SYRS | Common Stock | D | 2.000 | 2.000 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Olson Eric R | SYRS | Common Stock | D | 2,5800 | -623 | -2 | 7.350 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Olson Eric R | SYRS | Common Stock | D | 2.000 | 7.973 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2,5800 | -623 | -2 | 4.465 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Stephens Kristin | SYRS | Common Stock | D | 2.000 | 5.088 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 2,5800 | -1.852 | -5 | 73.420 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 6.000 | 75.272 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Haas Jason | SYRS | Common Stock | D | 2,5800 | -623 | -2 | 1.377 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Haas Jason | SYRS | Common Stock | D | 2.000 | 2.000 | ||||||
| 2023-04-04 | 2023-04-03 | 4 | Roth David | SYRS | Common Stock | D | 2,5800 | -623 | -2 | 7.348 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Roth David | SYRS | Common Stock | D | 2.000 | 7.971 | ||||||
| 2022-10-13 | 3 | Quirk Gerald E | SYRS | Common Stock | D | 8.700 | ||||||||
| 2022-10-03 | 2022-09-30 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 6,3704 | 14.000 | 89 | 24.932 | ||||
| 2022-10-03 | 2022-09-29 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 5,7196 | 2.932 | 17 | 10.932 | ||||
| 2022-09-19 | 2022-09-16 | 4 | WIRTH PETER | SYRS | Common Stock | D | 8.000 | 8.000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | Fanucci Marsha | SYRS | Common Stock | D | 8.000 | 8.000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | OH ANDREW M. | SYRS | Common Stock | D | 8.000 | 8.000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | TYSON TIMOTHY | SYRS | Common Stock | D | 8.000 | 8.000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | Eckhardt Sue Gail | SYRS | Common Stock | D | 8.000 | 8.000 | ||||||
| 2022-09-19 | 2022-09-16 | 4 | Dunsire Deborah | SYRS | Common Stock | D | 8.000 | 8.000 | ||||||
| 2022-04-04 | 2022-04-01 | 4 | Roth David | SYRS | Common Stock | D | 1,1200 | -27.281 | -31 | 59.719 | ||||
| 2022-04-04 | 2022-04-01 | 4 | Stephens Kristin | SYRS | Common Stock | D | 1,1200 | -14.115 | -16 | 30.885 | ||||
| 2022-04-04 | 2022-04-01 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 1,1200 | -58.883 | -66 | 692.723 | ||||
| 2022-04-04 | 2022-04-01 | 4 | Olson Eric R | SYRS | Common Stock | D | 1,1200 | -27.266 | -31 | 59.734 | ||||
| 2022-02-17 | 2022-02-15 | 4 | Simonian Nancy A | SYRS | Restricted Stock Units | D | 400.000 | 400.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Simonian Nancy A | SYRS | Restricted Stock Units | D | 240.000 | 240.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 1,59 | 375.000 | 375.000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Roth David | SYRS | Restricted Stock Units | D | 200.000 | 200.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Roth David | SYRS | Restricted Stock Units | D | 80.000 | 80.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 1,59 | 125.000 | 125.000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Olson Eric R | SYRS | Restricted Stock Units | D | 200.000 | 200.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Olson Eric R | SYRS | Restricted Stock Units | D | 80.000 | 80.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1,59 | 100.000 | 100.000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Stephens Kristin | SYRS | Restricted Stock Units | D | 200.000 | 200.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Stephens Kristin | SYRS | Restricted Stock Units | D | 80.000 | 80.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Stephens Kristin | SYRS | Stock Option (right to buy) | D | 1,59 | 100.000 | 100.000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Haas Jason | SYRS | Restricted Stock Units | D | 80.000 | 80.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Haas Jason | SYRS | Stock Option (right to buy) | D | 1,59 | 125.000 | 125.000 | |||||
| 2022-02-17 | 2022-02-15 | 4 | Chee Conley | SYRS | Restricted Stock Units | D | 80.000 | 80.000 | ||||||
| 2022-02-17 | 2022-02-15 | 4 | Chee Conley | SYRS | Stock Option (right to buy) | D | 1,59 | 100.000 | 100.000 | |||||
| 2022-01-06 | 2022-01-05 | 4 | Olson Eric R | SYRS | Common Stock | D | 3,4669 | -2.208 | -8 | 0 | ||||
| 2021-10-13 | 2021-10-12 | 4 | Haas Jason | SYRS | Stock Option (right to buy) | D | 4,54 | 750.000 | 750.000 | |||||
| 2021-09-28 | 2021-09-27 | 4 | Chee Conley | SYRS | Stock Option (right to buy) | D | 4,81 | 360.000 | 360.000 | |||||
| 2021-09-10 | 2021-09-09 | 4 | Dunsire Deborah | SYRS | Stock Option (right to buy) | D | 5,28 | 35.000 | 35.000 | |||||
| 2021-07-01 | 2021-07-01 | 4 | Olson Eric R | SYRS | Common Stock | D | 5,5500 | -1.164 | -6 | 0 | ||||
| 2021-06-10 | 2021-06-08 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 6,30 | 17.500 | 17.500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 6,30 | 17.500 | 17.500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | WIRTH PETER | SYRS | Stock Option (right to buy) | D | 6,30 | 17.500 | 17.500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 6,30 | 17.500 | 17.500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 6,30 | 17.500 | 17.500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 6,30 | 17.500 | 17.500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Eckhardt Sue Gail | SYRS | Stock Option (right to buy) | D | 6,30 | 17.500 | 17.500 | |||||
| 2021-06-10 | 2021-06-08 | 4 | Alles Mark J | SYRS | Stock Option (right to buy) | D | 6,30 | 17.500 | 17.500 | |||||
| 2021-06-10 | 3 | Stephens Kristin | SYRS | Common Stock | D | 45.000 | ||||||||
| 2021-03-17 | 2021-03-15 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1,01 | -3.628 | 90.697 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Olson Eric R | SYRS | Common Stock | D | 9,4740 | -3.628 | -34 | 0 | ||||
| 2021-03-17 | 2021-03-15 | 4 | Olson Eric R | SYRS | Common Stock | D | 1,0100 | 3.628 | 4 | 3.628 | ||||
| 2021-02-19 | 2021-02-17 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 11,41 | 94.000 | 94.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 11,41 | 94.000 | 94.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 11,41 | 94.000 | 94.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 11,41 | 119.000 | 119.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 11,41 | 119.000 | 119.000 | |||||
| 2021-02-19 | 2021-02-17 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 11,41 | 304.000 | 304.000 | |||||
| 2021-02-18 | 2021-02-16 | 4 | Young Richard A | SYRS | Common Stock | D | 12,0500 | -3.750 | -45 | 321.711 | ||||
| 2021-02-10 | 2020-11-17 | 4/A | Young Richard A | SYRS | Common Stock | D | 8,7500 | -5.357 | -47 | 329.211 | ||||
| 2021-02-10 | 2020-11-16 | 4/A | Young Richard A | SYRS | Common Stock | D | 8,9800 | -633 | -6 | 334.568 | ||||
| 2021-02-10 | 2021-02-08 | 4 | Young Richard A | SYRS | Common Stock | D | 13,0400 | -3.750 | -49 | 325.461 | ||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 10,09 | -4.988 | 280.012 | |||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 8,51 | -14.168 | 79.165 | |||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3,04 | -10.761 | 21.524 | |||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 10,0900 | 4.988 | 50 | 563.606 | ||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 8,5100 | 14.168 | 121 | 558.618 | ||||
| 2020-12-21 | 2020-12-18 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 3,0400 | 10.761 | 33 | 544.450 | ||||
| 2020-12-11 | 2020-12-08 | 4 | AKKARAJU SRINIVAS | SYRS | Warrants (right to buy) | I | 11,00 | 156.250 | 156.250 | |||||
| 2020-12-11 | 2020-12-08 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 625.000 | 1.899.616 | ||||||
| 2020-11-18 | 2020-11-17 | 4 | Young Richard A | SYRS | Common Stock | D | 8,7500 | -5.357 | -47 | 339.211 | ||||
| 2020-11-18 | 2020-11-16 | 4 | Young Richard A | SYRS | Common Stock | D | 8,9800 | -633 | -6 | 344.568 | ||||
| 2020-10-19 | 2020-10-19 | 4 | Young Richard A | SYRS | Common Stock | D | 8,7500 | -5.673 | -50 | 335.201 | ||||
| 2020-10-16 | 2020-10-15 | 4 | Young Richard A | SYRS | Common Stock | D | 8,7500 | -317 | -3 | 340.874 | ||||
| 2020-09-16 | 2020-09-15 | 4 | Young Richard A | SYRS | Common Stock | D | 10,3900 | -5.990 | -62 | 341.191 | ||||
| 2020-09-09 | 2020-09-08 | 4 | Eckhardt Sue Gail | SYRS | Stock Option (right to buy) | D | 8,94 | 35.000 | 35.000 | |||||
| 2020-08-19 | 2020-08-17 | 4 | Young Richard A | SYRS | Common Stock | D | 12,5900 | -5.990 | -75 | 347.181 | ||||
| 2020-08-19 | 2020-08-18 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1,01 | -10.787 | 94.325 | |||||
| 2020-08-19 | 2020-08-18 | 4 | Olson Eric R | SYRS | Common Stock | D | 13,0000 | -10.787 | -140 | 0 | ||||
| 2020-08-19 | 2020-08-18 | 4 | Olson Eric R | SYRS | Common Stock | D | 1,0100 | 10.787 | 11 | 10.787 | ||||
| 2020-08-19 | 2020-08-17 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1,01 | -4.963 | 105.112 | |||||
| 2020-08-19 | 2020-08-17 | 4 | Olson Eric R | SYRS | Common Stock | D | 13,0000 | -4.963 | -65 | 0 | ||||
| 2020-08-19 | 2020-08-17 | 4 | Olson Eric R | SYRS | Common Stock | D | 1,0100 | 4.963 | 5 | 4.963 | ||||
| 2020-08-19 | 2020-08-18 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 13,0955 | -158.583 | -2.077 | 1.274.616 | ||||
| 2020-08-19 | 2020-08-17 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 13,0000 | -744 | -10 | 1.433.199 | ||||
| 2020-07-17 | 2020-07-15 | 4 | Young Richard A | SYRS | Common Stock | D | 11,8500 | -5.990 | -71 | 353.171 | ||||
| 2020-07-07 | 2020-07-07 | 4 | Olson Eric R | SYRS | Common Stock | D | 11,7162 | -1.753 | -21 | 0 | ||||
| 2020-07-06 | 2020-07-01 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 11,0149 | -4.627 | -51 | 1.433.943 | ||||
| 2020-06-25 | 2020-06-25 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 11,1484 | -54.972 | -613 | 1.438.570 | ||||
| 2020-06-25 | 2020-06-24 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 11,0669 | -48.775 | -540 | 1.493.542 | ||||
| 2020-06-25 | 2020-06-23 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 11,1069 | -50.953 | -566 | 1.542.317 | ||||
| 2020-06-16 | 2020-06-15 | 4 | Young Richard A | SYRS | Common Stock | D | 8,7500 | -5.990 | -52 | 359.161 | ||||
| 2020-06-11 | 2020-06-11 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 9,17 | 17.500 | 17.500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | WIRTH PETER | SYRS | Stock Option (right to buy) | D | 9,17 | 17.500 | 17.500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 9,17 | 17.500 | 17.500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 9,17 | 17.500 | 17.500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | Alles Mark J | SYRS | Stock Option (right to buy) | D | 9,17 | 17.500 | 17.500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 9,17 | 17.500 | 17.500 | |||||
| 2020-06-11 | 2020-06-11 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 9,17 | 17.500 | 17.500 | |||||
| 2020-05-15 | 2020-05-15 | 4 | Young Richard A | SYRS | Common Stock | D | 9,2224 | -5.990 | -55 | 365.151 | ||||
| 2020-05-13 | 2020-05-13 | 4 | Alles Mark J | SYRS | Common Stock | D | 8,8590 | 10.000 | 89 | 10.000 | ||||
| 2020-04-17 | 2020-04-15 | 4 | Young Richard A | SYRS | Common Stock | D | 8,7500 | -23.960 | -210 | 371.141 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Olson Eric R | SYRS | Common Stock | D | 7,3818 | -1.446 | -11 | 0 | ||||
| 2020-02-14 | 2020-02-13 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 7,54 | 294.000 | 294.000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 7,54 | 94.000 | 94.000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 7,54 | 94.000 | 94.000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 7,54 | 94.000 | 94.000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 7,54 | 94.000 | 94.000 | |||||
| 2020-02-14 | 2020-02-13 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 7,54 | 94.000 | 94.000 | |||||
| 2019-12-23 | 2019-12-23 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3,04 | -8.210 | 1.018.123 | |||||
| 2019-12-23 | 2019-12-23 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3,04 | -10.762 | 1.026.333 | |||||
| 2019-12-23 | 2019-12-23 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3,04 | -33.429 | 1.037.095 | |||||
| 2019-12-23 | 2019-12-23 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 3,0400 | 52.401 | 159 | 533.689 | ||||
| 2019-12-20 | 2019-12-19 | 4 | Alles Mark J | SYRS | Stock Option (right to buy) | D | 6,22 | 35.000 | 35.000 | |||||
| 2019-11-12 | 2019-11-12 | 4 | Springhorn Jeremy P. | SYRS | Common Stock | D | 4,9667 | 10.121 | 50 | 35.000 | ||||
| 2019-11-12 | 2019-11-11 | 4 | Springhorn Jeremy P. | SYRS | Common Stock | D | 4,9932 | 9.879 | 49 | 24.879 | ||||
| 2019-08-19 | 2019-08-16 | 4 | Young Richard A | SYRS | Common Stock | D | 10,0000 | -22.700 | -227 | 395.101 | ||||
| 2019-08-19 | 2019-08-15 | 4 | Young Richard A | SYRS | Common Stock | D | 10,0000 | -2.300 | -23 | 417.801 | ||||
| 2019-07-17 | 2019-07-17 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 7,6964 | -34.521 | -266 | 4.242.051 | ||||
| 2019-07-17 | 2019-07-16 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 7,8078 | -25.779 | -201 | 4.276.572 | ||||
| 2019-07-17 | 2019-07-15 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 8,2651 | -2.700 | -22 | 4.302.051 | ||||
| 2019-06-12 | 2019-06-11 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 5,60 | 11.000 | 11.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Shaw Alice Tsang | SYRS | Stock Option (right to buy) | D | 5,60 | 22.000 | 22.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | WIRTH PETER | SYRS | Stock Option (right to buy) | D | 5,60 | 11.000 | 11.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 5,60 | 11.000 | 11.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 5,60 | 11.000 | 11.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | BONNEY MICHAEL W | SYRS | Stock Option (right to buy) | D | 5,60 | 11.000 | 11.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Fanucci Marsha | SYRS | Common Stock (right to buy) | D | 5,60 | 11.000 | 11.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 5,60 | 11.000 | 11.000 | |||||
| 2019-06-12 | 2019-06-11 | 4 | SATO VICKI L | SYRS | Common Stock (right to buy) | D | 5,60 | 11.000 | 11.000 | |||||
| 2019-04-11 | 2019-04-09 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock Warrants (rights to buy) | I | 8,62 | 133.333 | 133.333 | |||||
| 2019-04-11 | 2019-04-09 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 7,5000 | 533.332 | 4.000 | 1.593.270 | ||||
| 2019-03-14 | 2019-03-14 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 8,1498 | -43.000 | -350 | 4.305.051 | ||||
| 2019-03-14 | 2019-03-13 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 8,1993 | -2.820 | -23 | 4.348.051 | ||||
| 2019-03-14 | 2019-03-13 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 7,8862 | -81.591 | -643 | 4.350.871 | ||||
| 2019-03-14 | 2019-03-12 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 7,3674 | -40.092 | -295 | 4.432.462 | ||||
| 2019-03-11 | 2019-03-11 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 6,4924 | -44.878 | -291 | 4.472.554 | ||||
| 2019-03-11 | 2019-03-08 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 6,9266 | -84.496 | -585 | 4.517.432 | ||||
| 2019-03-11 | 2019-03-07 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 6,8736 | -35.209 | -242 | 4.601.928 | ||||
| 2019-02-14 | 2019-02-12 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 6,71 | 75.000 | 75.000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Ferra Joseph J Jr | SYRS | Common Stock | D | 87.000 | 87.000 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 6,71 | 75.000 | 75.000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Olson Eric R | SYRS | Common Stock | D | 87.000 | 87.000 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 6,71 | 75.000 | 75.000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Quirk Gerald E | SYRS | Common Stock | D | 87.000 | 87.000 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 6,71 | 75.000 | 75.000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Roth David | SYRS | Common Stock | D | 87.000 | 87.000 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 6,71 | 285.000 | 285.000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 188.000 | 669.288 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 6,71 | 75.000 | 75.000 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Springhorn Jeremy P. | SYRS | Common Stock | D | 87.000 | 102.000 | ||||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 3,04 | 12.084 | 785.523 | |||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 1,01 | 75.050 | 797.607 | |||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 1,01 | 23.454 | 872.657 | |||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 3,0400 | 12.084 | 37 | 481.288 | ||||
| 2018-12-03 | 2018-11-29 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 1,0100 | 98.504 | 99 | 469.204 | ||||
| 2018-06-15 | 2018-06-14 | 4 | BONNEY MICHAEL W | SYRS | Stock Option (right to buy) | D | 12,95 | 13.000 | 13.000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 12,95 | 11.000 | 11.000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 12,95 | 11.000 | 11.000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | SATO VICKI L | SYRS | Stock Option (right to buy) | D | 12,95 | 11.000 | 11.000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 12,95 | 11.000 | 11.000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | WIRTH PETER | SYRS | Stock Option (right to buy) | D | 12,95 | 11.000 | 11.000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 12,95 | 11.000 | 11.000 | |||||
| 2018-06-15 | 2018-06-14 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 12,95 | 11.000 | 11.000 | |||||
| 2018-03-12 | 2018-03-12 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 12,32 | 50.000 | 50.000 | |||||
| 2018-03-12 | 2018-03-12 | 4 | Ferra Joseph J Jr | SYRS | Stock Option (right to buy) | D | 12,32 | 150.000 | 150.000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 10,09 | 75.000 | 75.000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 13,30 | 11.666 | 11.666 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 10,09 | 75.000 | 75.000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 10,09 | 285.000 | 285.000 | |||||
| 2018-02-21 | 2018-02-16 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 10,09 | 75.000 | 75.000 | |||||
| 2018-02-13 | 2017-09-08 | 5 | AFEYAN NOUBAR | SYRS | Common Stock | D | -24.527 | 0 | ||||||
| 2018-02-02 | 2018-01-31 | 4 | AKKARAJU SRINIVAS see footnote 1 | SYRS | Common Stock | I | 9,5500 | 209.424 | 2.000 | 1.059.938 | ||||
| 2017-12-22 | 3/A | AKKARAJU SRINIVAS By Samsara BioCapital, L.P. | SYRS | Common Stock | I | 740.740 | ||||||||
| 2017-12-15 | 2017-12-15 | 4 | Springhorn Jeremy P. | SYRS | Common Stock | D | 9,0840 | 15.000 | 136 | 15.000 | ||||
| 2017-12-14 | 2017-12-14 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 8,9900 | 26.600 | 239 | 830.494 | ||||
| 2017-12-14 | 2017-12-13 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 8,9700 | 68.400 | 614 | 803.894 | ||||
| 2017-12-14 | 2017-12-12 | 4 | AKKARAJU SRINIVAS | SYRS | Common Stock | I | 9,4000 | 14.774 | 139 | 735.494 | ||||
| 2017-11-14 | 2017-11-13 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 11,65 | 50.000 | 50.000 | |||||
| 2017-11-14 | 2017-11-13 | 4 | Springhorn Jeremy P. | SYRS | Stock Option (right to buy) | D | 11,65 | 150.000 | 150.000 | |||||
| 2017-10-23 | 2017-10-23 | 4 | DeSimone Colleen Elizabeth | SYRS | Stock Option (right to buy) | D | 3,04 | -550 | 13.016 | |||||
| 2017-10-23 | 2017-10-23 | 4 | DeSimone Colleen Elizabeth | SYRS | Common Stock | D | 16,0605 | -550 | -9 | 0 | ||||
| 2017-10-23 | 2017-10-23 | 4 | DeSimone Colleen Elizabeth | SYRS | Common Stock | D | 3,0400 | 550 | 2 | 550 | ||||
| 2017-09-22 | 2017-06-08 | 4/A | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 14,62 | 22.000 | 22.000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 14,62 | 11.000 | 11.000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | Nashat Amir | SYRS | Stock Option (right to buy) | D | 14,62 | 11.000 | 11.000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | Patel Sanj K | SYRS | Stock Option (right to buy) | D | 14,62 | 11.000 | 11.000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | SATO VICKI L | SYRS | Stock Option (right to buy) | D | 14,62 | 11.000 | 11.000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 14,62 | 11.000 | 11.000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | Young Richard A | SYRS | Stock Option (right to buy) | D | 14,62 | 11.000 | 11.000 | |||||
| 2017-09-22 | 2017-06-08 | 4/A | NELSEN ROBERT | SYRS | Stock Option (right to buy) | D | 14,62 | 11.000 | 11.000 | |||||
| 2017-08-21 | 2017-08-17 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | -54.293 | 0 | ||||||
| 2017-08-21 | 2017-08-17 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | -306.222 | 612.442 | ||||||
| 2017-08-21 | 2017-08-17 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | D | -1.295.997 | 2.378.663 | ||||||
| 2017-08-16 | 2017-08-14 | 4 | Young Richard A | SYRS | Common Stock | D | 22,0000 | -3.282 | -72 | 420.101 | ||||
| 2017-08-08 | 2017-08-07 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1,01 | 2.500 | 110.075 | |||||
| 2017-08-08 | 2017-08-07 | 4 | Olson Eric R | SYRS | Common Stock | D | 23,5876 | -2.500 | -59 | 0 | ||||
| 2017-08-08 | 2017-08-07 | 4 | Olson Eric R | SYRS | Common Stock | D | 1,0100 | 2.500 | 3 | 2.500 | ||||
| 2017-07-27 | 2017-07-25 | 4 | Young Richard A | SYRS | Common Stock | D | 22,0889 | -3.282 | -72 | 423.383 | ||||
| 2017-07-27 | 2017-07-25 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 1,01 | 12.500 | 25.025 | |||||
| 2017-07-27 | 2017-07-25 | 4 | Olson Eric R | SYRS | Common Stock | D | 21,8500 | -12.500 | -273 | 0 | ||||
| 2017-07-27 | 2017-07-25 | 4 | Olson Eric R | SYRS | Common Stock | D | 1,0100 | 12.500 | 13 | 12.500 | ||||
| 2017-06-12 | 3 | AKKARAJU SRINIVAS by Samsara BioCapital, L.P. | SYRS | Common Stock | I | 1.441.440 | ||||||||
| 2017-06-12 | 3 | AKKARAJU SRINIVAS by Samsara BioCapital, L.P. | SYRS | Common Stock | I | 1.441.440 | ||||||||
| 2017-06-12 | 2017-06-08 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 14,26 | 11.000 | 11.000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 14,26 | 11.000 | 11.000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | SATO VICKI L | SYRS | Stock Option (right to buy) | D | 14,26 | 11.000 | 11.000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | NELSEN ROBERT | SYRS | Stock Option (right to buy) | D | 14,26 | 11.000 | 11.000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Patel Sanj K | SYRS | Stock Option (right to buy) | D | 14,26 | 11.000 | 11.000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 14,26 | 11.000 | 11.000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 14,26 | 11.000 | 11.000 | |||||
| 2017-06-12 | 2017-06-08 | 4 | AKKARAJU SRINIVAS | SYRS | Stock Option (right to buy) | D | 14,26 | 22.000 | 22.000 | |||||
| 2017-02-13 | 2017-02-09 | 5 | Young Richard A | SYRS | Common Stock | D | -106.667 | 426.665 | ||||||
| 2017-02-13 | 2017-02-10 | 4 | Roth David | SYRS | Stock Option (right to buy) | D | 10,90 | 63.500 | 63.500 | |||||
| 2017-02-13 | 2017-02-10 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 10,90 | 40.000 | 40.000 | |||||
| 2017-02-13 | 2017-02-10 | 4 | Olson Eric R | SYRS | Stock Option (right to buy) | D | 10,90 | 63.500 | 63.500 | |||||
| 2017-02-13 | 2017-02-10 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 10,90 | 175.000 | 175.000 | |||||
| 2017-02-13 | 2017-02-10 | 4 | Kuvalanka Kyle D. | SYRS | Stock Option (right to buy) | D | 10,90 | 78.000 | 78.000 | |||||
| 2017-01-30 | 2017-01-27 | 4 | WIRTH PETER | SYRS | Stock Option (Right to Buy) | D | 10,76 | 22.000 | 22.000 | |||||
| 2016-09-29 | 2016-09-27 | 4 | Quirk Gerald E | SYRS | Stock Option (right to buy) | D | 13,30 | 105.000 | 105.000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | NELSEN ROBERT | SYRS | Stock Option (right to buy) | D | 12,59 | 22.000 | 22.000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Fanucci Marsha | SYRS | Stock Option (right to buy) | D | 12,59 | 22.000 | 22.000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Young Richard A | SYRS | Stock Option (right to buy) | D | 12,59 | 22.000 | 22.000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Bancel Stephane | SYRS | Stock Option (right to buy) | D | 12,59 | 22.000 | 22.000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | SHARP PHILIP A | SYRS | Stock Option (right to buy) | D | 12,59 | 22.000 | 22.000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Patel Sanj K | SYRS | Stock Option (right to buy) | D | 12,59 | 22.000 | 22.000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | SATO VICKI L | SYRS | Stock Option (right to buy) | D | 12,59 | 22.000 | 22.000 | |||||
| 2016-09-19 | 2016-09-16 | 4 | Simonian Nancy A | SYRS | Stock Option (right to buy) | D | 12,17 | 75.000 | 75.000 | |||||
| 2016-09-19 | 2016-09-15 | 4 | Nashat Amir | SYRS | Stock Option (right to buy) | D | 12,59 | 22.000 | 22.000 | |||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Series B Preferred Stock | D | -1.589.269 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Series A-3 Preferred Stock | D | -7.500.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Series A-2 Preferred Stock | D | -5.000.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Series A-1 Preferred Stock | D | -1.000.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 12,5000 | 400.000 | 5.000 | 4.637.137 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 423.805 | 4.237.137 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 2.000.000 | 3.813.332 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 1.333.333 | 1.813.332 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Arch Venture Fund VII LP | SYRS | Common Stock | D | 266.666 | 479.999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Series B Preferred Stock | I | -83.129 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Series B Preferred Stock | I | -4.366.825 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Common Stock | I | 12,5000 | 26.153 | 327 | 48.320 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Common Stock | I | 12,5000 | 373.847 | 4.673 | 1.538.333 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Common Stock | I | 22.167 | 22.167 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Nashat Amir | SYRS | Common Stock | I | 1.164.486 | 1.164.486 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series B Preferred Stock | I | -444.995 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series B Preferred Stock | I | -1.779.981 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-3 Preferred Stock | I | -1.500.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-3 Preferred Stock | I | -6.000.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-2 Preferred Stock | I | -1.000.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-2 Preferred Stock | I | -4.000.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-1 Preferred Stock | I | -200.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Series A-1 Preferred Stock | I | -800.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 12,5000 | 80.000 | 1.000 | 918.664 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 12,5000 | 320.000 | 4.000 | 3.674.660 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 118.665 | 838.664 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 474.661 | 3.354.660 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 400.000 | 719.999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 1.600.000 | 2.879.999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 266.666 | 319.999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 1.066.666 | 1.279.999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 53.333 | 53.333 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Flagship Ventures Fund IV, L.P. | SYRS | Common Stock | I | 213.333 | 213.333 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -151.576 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -117.931 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -982.762 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -178.074 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Series B Preferred Stock | D | -317.853 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 12,5000 | 9.373 | 117 | 49.793 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 12,5000 | 174.320 | 2.179 | 205.767 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 12,5000 | 104.670 | 1.308 | 366.739 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 12,5000 | 144.383 | 1.805 | 191.869 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 40.420 | 40.420 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 31.447 | 31.447 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 262.069 | 262.069 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 47.486 | 47.486 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Redmile Group, LLC | SYRS | Common Stock | D | 84.760 | 84.760 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Series B Preferred Stock | D | -1.994.471 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Series A-3 Preferred Stock | D | -500.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Series A-1 Preferred Stock | D | -500.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Series A-2 Preferred Stock | D | -500.000 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Common Stock | D | 531.858 | 931.857 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Common Stock | D | 133.333 | 399.999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Common Stock | D | 133.333 | 399.999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | WuXi PharmTech Healthcare Fund I L.P. | SYRS | Common Stock | D | 133.333 | 399.999 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Series B Preferred Stock | I | -83.129 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Series B Preferred Stock | I | -4.366.825 | 0 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Common Stock | I | 12,5000 | 26.153 | 327 | 48.320 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Common Stock | I | 12,5000 | 373.847 | 4.673 | 1.538.333 | ||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Common Stock | I | 22.167 | 22.167 | ||||||
| 2016-07-07 | 2016-07-06 | 4 | Polaris Management Co. VII, L.L.C. | SYRS | Common Stock | I | 1.164.486 | 1.164.486 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | AISLING CAPITAL III LP | SYRS | Series B Preferred Stock | D | -1.907.122 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | AISLING CAPITAL III LP | SYRS | Common Stock | D | 12,5000 | 400.000 | 5.000 | 908.565 | ||||
| 2016-07-06 | 2016-07-06 | 4 | AISLING CAPITAL III LP | SYRS | Common Stock | D | 508.565 | 508.565 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Series B Preferred Stock | I | -1.589.269 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Series A-3 Preferred Stock | I | -7.500.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Series A-2 Preferred Stock | I | -5.000.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Series A-1 Preferred Stock | I | -1.000.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 12,5000 | 400.000 | 5.000 | 4.637.137 | ||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 423.805 | 4.237.137 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 2.000.000 | 3.813.332 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 1.333.333 | 1.813.332 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | NELSEN ROBERT | SYRS | Common Stock | I | 266.666 | 479.999 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Simonian Nancy A | SYRS | Series A-2 Preferred Stock | D | -250.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Simonian Nancy A | SYRS | Common Stock | D | 66.666 | 370.702 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Series A-2 Preferred Stock | I | -150.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Series A-2 Preferred Stock | I | -150.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Series A-2 Preferred Stock | I | -150.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Series A-2 Preferred Stock | D | -550.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Common Stock | I | 40.000 | 40.000 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Common Stock | I | 40.000 | 40.000 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Common Stock | I | 40.000 | 40.000 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | SHARP PHILIP A | SYRS | Common Stock | D | 146.666 | 146.666 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Bancel Stephane | SYRS | Series A-2 Preferred Stock | D | -100.000 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Bancel Stephane | SYRS | Common Stock | D | 26.666 | 47.980 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | SYRS | Series B Convertible Preferred Stock | I | -508.566 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | SYRS | Series B Convertible Preferred Stock | I | -1.186.654 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | SYRS | Common Stock | I | 12,5000 | 120.000 | 1.500 | 628.566 | ||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | SYRS | Common Stock | I | 12,5000 | 280.000 | 3.500 | 1.466.654 | ||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | SYRS | Common Stock | I | 508.566 | 508.566 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | Flynn James E Through Deerfield Private Design Fund III, L.P. | SYRS | Common Stock | I | 1.186.654 | 1.186.654 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | WuXi Healthcare Ventures II, L.P. | SYRS | Series B Preferred Stock | D | -1.589.269 | 0 | ||||||
| 2016-07-06 | 2016-07-06 | 4 | WuXi Healthcare Ventures II, L.P. | SYRS | Common Stock | D | 423.805 | 423.805 | ||||||
| 2016-06-29 | 3 | Gray Nathanael | SYRS | Common Stock | D | 853.332 | ||||||||
| 2016-06-29 | 3 | Gray Nathanael | SYRS | Common Stock | D | 853.332 | ||||||||
| 2016-06-29 | 3 | JEB Syros Trust | SYRS | Common Stock | D | 703.332 | ||||||||
| 2016-06-29 | 3 | JEB Syros Trust | SYRS | Common Stock | D | 703.332 | ||||||||
| 2016-06-29 | 3 | Bancel Stephane | SYRS | Common Stock | D | 42.628 | ||||||||
| 2016-06-29 | 3 | Bancel Stephane | SYRS | Common Stock | D | 42.628 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A | SYRS | Common Stock | D | 768.072 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o William H. Cole | SYRS | Common Stock | I | 544.036 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o Bennett H. Cole | SYRS | Common Stock | I | 544.036 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o William H. Cole | SYRS | Common Stock | I | 544.036 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A By the Douglas and Nancy Cole Family Trust f/b/o Bennett H. Cole | SYRS | Common Stock | I | 544.036 | ||||||||
| 2016-06-29 | 3 | Simonian Nancy A | SYRS | Common Stock | D | 768.072 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426.664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426.664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426.664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426.664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426.664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426.664 | ||||||||
| 2016-06-29 | 3 | KANIA EDWIN M JR | SYRS | Common Stock | I | 426.664 | ||||||||
| 2016-06-29 | 3 | NELSEN ROBERT Shares held by ARCH Venture Fund VII, L.P. | SYRS | Common Stock | I | 426.666 | ||||||||
| 2016-06-29 | 3 | NELSEN ROBERT Shares held by ARCH Venture Fund VII, L.P. | SYRS | Common Stock | I | 426.666 | ||||||||
| 2016-06-29 | 3 | Perspecta Trust LLC Owned by the JEB Syros Trust, of which Perspecta Trust LLC is trustee. | SYRS | Common Stock | I | 703.332 | ||||||||
| 2016-06-29 | 3 | Perspecta Trust LLC Owned by the JEB Syros Trust, of which Perspecta Trust LLC is trustee. | SYRS | Common Stock | I | 703.332 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426.666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426.666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426.666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426.666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426.666 | ||||||||
| 2016-06-29 | 3 | BYBEE CLINTON | SYRS | Common Stock | D | 426.666 | ||||||||
| 2016-06-29 | 3 | Young Richard A | SYRS | Common Stock | D | 1.066.664 | ||||||||
| 2016-06-29 | 3 | Young Richard A | SYRS | Common Stock | D | 1.066.664 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
